1.Tranexamic acid-fatty alcohol polyoxyethylene ether conjugation/PVA foam for venous sclerotherapy via vascular damage and inhibiting plasmin system.
Jizhuang MA ; Keda ZHANG ; Wenhan LI ; Yu DING ; Yongfeng CHEN ; Xiaoyu HUANG ; Tong YU ; Di SONG ; Haoran NIU ; Huichao XIE ; Tianzhi YANG ; Xiaoyun ZHAO ; Xinggang YANG ; Pingtian DING
Acta Pharmaceutica Sinica B 2025;15(6):3291-3304
Venous system diseases mainly include varicose veins and venous malformations of lower limbs and the genital system. Most of them are chronic diseases that cause serious clinical symptoms to patients and affect their health and quality of life. Sclerotherapy has become the first-line therapy for venous system diseases. However, there are problems such as incomplete fibrosis and vascular recanalization after sclerotherapy, and improper operation will cause serious adverse consequences. Therefore, exploring a safe and effective sclerotherapy strategy is essential for developing clinically successful sclerotherapy. To solve the above problems, we proposed a new sclerotherapy strategy with a dual mechanism of "vascular damage and plasmin (PLA) system inhibition." We intended to construct a novel cationic surfactant (AEOx-TA) by reacting tranexamic acid (TA), a parent structure, with fatty alcohol polyoxyethylene ether (AEOx) by ester bonds. AEOx-TA could damage vascular endothelium and initiate a coagulation cascade effect to induce thrombus. Furthermore, AEOx-TA could be degraded by esterase and release the parent drug, TA, which could inhibit the PLA system to inhibit the degradation of thrombus and extracellular matrix and promote the process of vascular fibrosis. In addition, such surfactant-based sclerosants have foam-forming properties, and they can be blended with polyvinyl alcohol (PVA) to prepare a highly stable foam formulation (AEOx-TA/P), which can achieve a precise drug delivery and prolonged drug retention time, thereby improving drug efficacy and reducing the risk of ectopic embolism. Overall, the novel cationic surfactant AEOx-TA provides a new avenue to resolve the bottleneck: surfactant sclerosants' efficiency is relatively low in the current sclerotherapy.
2.Genome-wide investigation of transcription factor footprints and dynamics using cFOOT-seq.
Heng WANG ; Ang WU ; Meng-Chen YANG ; Di ZHOU ; Xiyang CHEN ; Zhifei SHI ; Yiqun ZHANG ; Yu-Xin LIU ; Kai CHEN ; Xiaosong WANG ; Xiao-Fang CHENG ; Baodan HE ; Yutao FU ; Lan KANG ; Yujun HOU ; Kun CHEN ; Shan BIAN ; Juan TANG ; Jianhuang XUE ; Chenfei WANG ; Xiaoyu LIU ; Jiejun SHI ; Shaorong GAO ; Jia-Min ZHANG
Protein & Cell 2025;16(11):932-952
Gene regulation relies on the precise binding of transcription factors (TFs) at regulatory elements, but simultaneously detecting hundreds of TFs on chromatin is challenging. We developed cFOOT-seq, a cytosine deaminase-based TF footprinting assay, for high-resolution, quantitative genome-wide assessment of TF binding in both open and closed chromatin regions, even with small cell numbers. By utilizing the dsDNA deaminase SsdAtox, cFOOT-seq converts accessible cytosines to uracil while preserving genomic integrity, making it compatible with techniques like ATAC-seq for sensitive and cost-effective detection of TF occupancy at the single-molecule and single-cell level. Our approach enables the delineation of TF footprints, quantification of occupancy, and examination of chromatin influences on TF binding. Notably, cFOOT-seq, combined with FootTrack analysis, enables de novo prediction of TF binding sites and tracking of TF occupancy dynamics. We demonstrate its application in capturing cell type-specific TFs, analyzing TF dynamics during reprogramming, and revealing TF dependencies on chromatin remodelers. Overall, cFOOT-seq represents a robust approach for investigating the genome-wide dynamics of TF occupancy and elucidating the cis-regulatory architecture underlying gene regulation.
Transcription Factors/genetics*
;
Humans
;
Chromatin/genetics*
;
Animals
;
Binding Sites
;
Mice
;
DNA Footprinting/methods*
3.Analysis of risk factors for central nervous system infection after craniotomy
Jiawei LIU ; Dawazhuoma ; Ting YE ; Xiaoyu ZHAO ; Di LIU ; Siqing MA
Chongqing Medicine 2025;54(5):1176-1179,1186
Objective To analyze the incidence and risk factors of central nervous system infection(CNSI)after craniotomy.Methods Clinical data from 1 432 patients who underwent craniotomy in the neuro-surgery department of the hospital from 2019 to 2021 were retrospectively collected,and the positive rates of CNSI after craniotomy in neurosurgery were analyzed.Univariate analysis and multivariate logistic regression analysis were adopted to identify the risk factors affecting the occurrence of CNSI.Results The positive rate of CNSI in 1 432 patients was 12.92%,and the positive rate of bacterial culture in cerebrospinal fluid samples was 2.88%.Univariate analysis showed that hypertension,length of hospital stay,preoperative length of hos-pital stay,intensive care unit(ICU)treatment,American Society of Anesthesiologists(ASA)grading,surgery time≥ 3 h,blood transfusion,cerebrospinal fluid leakage,and postoperative hormone use were influencing fac-tors for the occurrence of CNSI.Multivariate logistic regression analysis showed that hypertension(OR=1.475),length of hospital stay higher than 30 days(OR=2.498),length of ICU treatment(OR=2.381),length of surgery(OR=1.572)higher than 3 hours and cerebrospinal fluid leakage(OR=3.062)were inde-pendent risk factors for the occurrence of CNSI.Conclusion The positive rate of CNSI after craniotomy is rel-atively high,and there are many related risk factors.Medical staff should take relevant measures to address the risk factors,continuously carry out targeted monitoring,and provide a basis for clinical treatment.
4.Diabetes of the exocrine pancreas:recent advances
Xiaoyu ZHOU ; Di ZHANG ; Lianghao HU ; Zhaoshen LI
Academic Journal of Naval Medical University 2025;46(7):831-837
Diabetes of the exocrine pancreas(DEP)used to be called pancreatic diabetes,pancreatogenic diabetes or type 3c diabetes mellitus.Currently,the incidence of DEP is higher than that of type 1 diabetes mellitus.The pathogenesis and clinical manifestations of DEP are related to primary pancreatic diseases.In terms of management,we need to consider both pancreatic endocrine and exocrine functions,and comprehensively treat diabetes mellitus and primary pancreatic diseases.By now,there has been no guideline related to DEP;its diagnostic criteria,differentiation with type 2 diabetes mellitus,and selection of hypoglycemic programs are challenges in clinical practice.This article reviews the clinical studies related to DEP,and summarizes the evolution of its terminology,pathogenesis,clinical manifestations,complications,diagnosis,treatment and management.
5.Research progress on cell subpopulations of white and brown adipose tissue stromal vascular fraction based on single-cell sequencing technology
Chinese Journal of Plastic Surgery 2025;41(2):210-216
In recent years, the rise of single-cell sequencing technology has led to a new era in the study of the heterogeneity of stromal vascular fraction (SVF) in adipose tissue, revealing abundant previously undiscovered cell subsets. Based on single-cell sequencing technology, this paper reviewed the recent progress of SVF cell subsets in white and brown adipose tissue.
6.Classification and characteristics of adipose tissue
Chinese Journal of Plastic Surgery 2025;41(7):755-760
In recent years, advances in the study of adipose tissue have driven new breakthroughs in nutritional metabolism, tissue engineering, tumor prevention and treatment, and other related fields. Currently, there are a variety of classifications for adipose tissue, and this paper provides an overview of five different types of adipose tissue(white adipose tissue, brown adipose tissue, beige adipose tissue, yellow adipose tissue, and pink adipose tissue) and their respective properties.
7.Platinum Resistance in Ovarian Cancer:Limitations of PFI Binary Classification and Potential Improvements
Xiaoyu LI ; Nan ZHANG ; Wen DI
Cancer Research on Prevention and Treatment 2024;51(10):813-819
Ovarian cancer is a common gynecologic malignancy.In clinical practice,recurrent ovarian cancer is mainly classified into two categories on the basis of platinum-free interval,platinum-resistant and platinum-sensitive,corresponding to different treatment modalities and prognoses.The treatment of platinum-resistant ovarian cancer is challenging.Some scholars have pointed out limitations in the binary classification of platinum-free interval.In this article,the classification of recurrent ovarian cancer,the treatment challenges of platinum-resistant ovarian cancer,the limitations of the platinum-free interval binary classification,and new classification perspectives were reviewed to help physicians enhance their understanding on the research progress in ovarian cancer classification and develop more effective treatment strategies.
8.Research progress on cell subpopulations of white and brown adipose tissue stromal vascular fraction based on single-cell sequencing technology
Chinese Journal of Plastic Surgery 2024;40(6):587-593
In recent years, the rise of single-cell sequencing technology has led to a new era in the study of the heterogeneity of stromal vascular fraction (SVF) in adipose tissue, revealing many previously undiscovered cell subsets. Based on single-cell sequencing technology, this paper reviews the research progress of SVF cell subsets in white and brown adipose tissue.
9.Classification and characteristics of adipose tissue
Chinese Journal of Plastic Surgery 2024;40(9):1041-1046
In recent years, advances in the study of adipose tissue have driven new breakthroughs in nutritional metabolism, tissue engineering, tumor prevention and treatment, and other related fields. Currently, there are a variety of classifications for adipose tissue, and this paper provides an overview of five different types of adipose tissue(white adipose tissue, brown adipose tissue, beige adipose tissue, yellow adipose tissue, pink adipose tissue) and their respective properties.
10.Environmental and occupational health move forward together to create a new era of health: Minutes of the Eighteenth National Postgraduates Symposium on Environmental and Occupational Medicine
Yunjia ZHAO ; Yuan WANG ; Jiao CHEN ; Chenchen ZHANG ; Xinyi GU ; Di YI ; Xiaoyu WANG
Journal of Environmental and Occupational Medicine 2024;41(11):1297-1300
The 18th National Postgraduate Symposium on Environmental and Occupational Medicine, co-sponsored by the Editorial Board of Journal of Environmental and Occupational Medicine and the School of Public Health of Sun Yat-sen University, was successfully held on August 22 to 25, 2024 in Guangzhou, Guangdong Province, China. Adhering to the theme of “Research and practice: Healing the schism”, the symposium aims to enliven academic thinking, expand research horizons, encourage innovation, enhance inter-university exchanges, and strengthen talent cultivation, especially to promote the close integration of academic research and public health practice. A total of 105 papers were received from 38 universities. The symposium also gathered about 160 participants, mainly authors postgraduates from universities and experts and professors in the field of environmental and occupational medicine. All the participants discussed the latest research advances and future development trends of environmental and occupational medicine, and endeavor to apply the research results in public health practice.

Result Analysis
Print
Save
E-mail